Jump to content

3-Methoxyamphetamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 14:34, 2 April 2016 (Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

3-Methoxyamphetamine
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • ?
Identifiers
  • 1-(3-methoxyphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H15NO
Molar mass165.232 g/mol g·mol−1
3D model (JSmol)
  • NC(C)CC1=CC=CC(OC)=C1
  • InChI=1S/C10H15NO/c1-8(11)6-9-4-3-5-10(7-9)12-2/h3-5,7-8H,6,11H2,1-2H3 checkY
  • Key:VEJWNIYARKAHFI-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

meta-Methoxyamphetamine[1] (MMA), also known as 3-methoxyamphetamine (3-MA), is a stimulant drug from the amphetamine family. It has similar effects in animal drug discrimination tests to the more widely known derivative 4-methoxyamphetamine (PMA),[2] although with a slightly different ratio of monoamine release, being a combined serotonin, dopamine, and norepinephrine releasing agent rather than a fairly selective serotonin releaser like PMA.[3][4] 3-Methoxyamphetamine has similarly appeared on the illicit market as a designer drug alternative to MDMA, although far more rarely than its infamous positional isomer.[5] It produces gepefrine, a cardiac stimulant, as one of its major metabolites.[6]

See also

References

  1. ^ GB Patent 1527479 - ACID ADDITION SALTS OF D-(+)-1-(3-HYDROXYPHENYL)-2-AMINOPROPANE AND THEIR MANUFACTURE AND USE
  2. ^ Glennon, RA; Young, R; Hauck, AE (1985). "Structure-activity studies on methoxy-substituted phenylisopropylamines using drug discrimination methodology". Pharmacology, Biochemistry, and Behavior. 22 (5): 723–9. doi:10.1016/0091-3057(85)90520-9. PMID 3839309.
  3. ^ Tseng, LF; Menon, MK; Loh, HH (1976). "Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue". The Journal of Pharmacology and Experimental Therapeutics. 197 (2): 263–71. PMID 1271280.
  4. ^ Menon, MK; Tseng, LF; Loh, HH (1976). "Pharmacological evidence for the central serotonergic effects of monomethoxyamphetamines". The Journal of Pharmacology and Experimental Therapeutics. 197 (2): 272–9. PMID 946817.
  5. ^ Dal Cason, TA (2001). "A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone". Forensic Science International. 119 (2): 168–94. doi:10.1016/S0379-0738(00)00425-4. PMID 11376983.
  6. ^ Midha, KK; Cooper, JK; Bailey, K; Hubbard, JW (1981). "The metabolism of 3-methoxyamphetamine in dog, monkey and man". Xenobiotica. 11 (2): 137–46. doi:10.3109/00498258109045284. PMID 6894510.